SCHEMBL20530364

SCHEMBL20530364

CNC(=O)c1cccc(-c2ccc3nnn(Cc4cccc5cccnc45)c3n2)c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.47
PLK1 P53350 1/20 0.43
MET P08581 1/20 0.42
CSNK1D P48730 1/20 0.41
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SLC22A12 Q96S37 1/20 0.39
HDAC6 Q9UBN7 1/20 0.38
PDE2A O00408 1/20 0.38
PDE10A Q9Y233 1/20 0.38
SLC40A1 Q9NP59 1/20 0.38
ADORA3 P0DMS8 3/20 0.38
GPR84 Q9NQS5 2/20 0.38
FYN P06241 2/20 0.38
MAP4K1 Q92918 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20530341 0.92 HDAC6 (0.43) MAP4K4PLK1METSLC22A12HDAC6
SCHEMBL20530285 0.88 PDE4A (0.39) METSLC22A12HDAC6ADORA3FYN
SCHEMBL20530335 0.87 MET (0.47) METSLC22A12MEN1KMT2A
SCHEMBL20530349 0.87 MET (0.48) METPDE2APDE10A
SCHEMBL1330544 0.85 MET (0.54) PLK1MET
SCHEMBL20530355 0.82 RIPK1 (0.43) METHDAC6ADORA3KMT2A
SCHEMBL20530312 0.82 MET (0.39) METSLC22A12PDE10AFYN
SCHEMBL20530289 0.82 MET (0.43) MAP4K4MET
SCHEMBL20530354 0.81 AR (0.39) MAP4K4METSLC22A12HDAC6ADORA3
SCHEMBL2598848 0.81 MET (0.54) PLK1MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2571878-B1 NOVEL 3,5-DISUBSTITUED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUED -3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDINE COMPOUNDS AS MODULATORS OF PROTEIN KINASES INCOZEN THERAPEUTICS PVT LTD (IN) 2018-10-17 EP claimed